Table 2. Characteristics of studies included in the systematic review.
First author | Year | Country | GDM diagnosis criterion | Total women | No. with GDM | % with GDM | Risk factor screening strategy |
---|---|---|---|---|---|---|---|
Avalos[33] | 2013 | Ireland | IADPSG | 5500 | 521a |
9 |
Irish, NICE, ADA guideline recommendations |
491b | 9 | ||||||
585c | 11 | ||||||
Caliskan[39] | 2004 | Turkey | NDDG | 422 | 14 | 3 | Number of risk factors |
Cosson[34] | 2013 | France | WHO | 18755 | 2710 | 14 | French guideline recommendations |
Cypryk[40] | 2008 | Poland | WHO | 2180 | 510 | 23 | Number of risk factors |
Danilenko-Dixon[35] | 1999 | USA | NDDG | 18504 | 564 | 3 | ADA guideline recommendations |
Erum[51] | 2015 | Turkey | ADA | 815 | 39 | 5 | ‘At least one risk factor’ |
Gabbay-Benviz[58] | 2015 | USA | C&C | 924 | 63 | 7 | Risk score |
Jensen[61] | 2003 | Denmark | DPSG | 2992d | 83 | 3 | Number of risk factors |
Jiminez-moleon[36] | 2002 | Spain | NDDG | 1436 |
58c |
4 |
ADA and ACOG guideline recommendations |
2174 | 63e | 3 | |||||
Kirke[59] | 2014 | Australia | WHO | 1636 | 73 | 4 | Risk score |
Marquette[42] | 1985 | USA | C&C | 434 | 12 | 3 | Number of risk factors |
Moses[47] | 1998 | Australia | ADIPS | 2907 | 183 | 6 | Age, BMI ethnicity |
Nanda[52] | 2011 | UK | WHO | 11464 | 297 | 3 | Risk model |
Naylor[53] | 1997 | US | NDDG or C&C | 1571 | 69 | 4 | Risk score |
Nielsen[43] | 2016 | India | WHO | 3946 | 659 | 17 | Number of risk factors (1, 2 or 3) |
Ostlund[28] | 2003 | Sweden | WHO | 3616 | 61 | 5 | "Traditional risk factors" |
Phaloprakam[54] | 2009 | Thailand | C&C | 469 | 127 | 27 | Risk score |
Pintaudi[48] | 2014 | Italy | IADPSG | 1015 | 113 | 11 | "Standard risk factors" |
Sacks[44] | 1987 | USA | ADA | 4116 | 138 | 3 | Number of risk factors |
Savona-Ventura[49] | 2013 | Mediterranean | ADA | 1368 | 119 | 9 | Based on age, obesity or diastolic BP |
Shamsuddin[45] | 2001 | Malaysia | OGTT levels reported | 768 | 191 | 25 | Number of risk factors |
Shirazian[55] | 2009 | Iran | ADA | 924 | 68 | 7 | Risk score |
Sunsaneevithayakul[46] | 2003 | Thailand | Not reported | 9325 | 235 | 2 | Number of risk factors |
Syngelaki[60] | 2015 | UK | WHO | 75161 | 1827 | 20 | Risk model |
Teh[37] | 2011 | Australia | ADIPS | 2426 | 250 | 10 | NICE, ADA and ADIPS guideline recommendations |
van Leeuwen[57] (A) | 2010 | Netherlands | OGTT/GCT levels reported | 995 | 24 | 2 | Risk model |
van Leeuwen[56] (B) | 2009 | Netherlands | WHO | 1266 | 47 | 4 | Risk score |
Williams[50] | 1999 | USA | NDDG | 25118 | 210f | 1 | Based on age, BMI ethnicity, family history |
Yang[38] | 2002 | China | WHO | 9471 | 171 | 2 | ADA guideline |
aIrish guideline
bNICE guideline
cADA recommendations
dJensen (2003), 5235 women were included in the study, 2992 had an OGTT performed
eACOG recommendations
fWilliams (1999), number of women with GDM varied by the recorded risk factor (i.e. not all women had all risk factors recorded)
ACOG = American College of Obstetricians and Gynecologists
ADA = American Diabetes Association
ADIPS = Australasian Diabetes In Pregnancy Society
C&C = Carpenter and Coustan
NDDA = National Diabetes Data Group
NICE = National Institute for Health and Care Excellence
IADPSG = International Association of Diabetes in Pregnancy Study Groups
WHO = World Health Organization